NAD+激酶
烟酰胺单核苷酸
烟酰胺
烟酰胺磷酸核糖转移酶
医学
烟酰胺腺嘌呤二核苷酸
内科学
化学
生物
内分泌学
生物信息学
生物化学
酶
作者
Claudia Montllor-Albalate,Zehan Song,Danica Chen
标识
DOI:10.1016/j.cmet.2021.06.008
摘要
Numerous preclinical studies implicate the decline in NAD+ signaling in developing aging- and obesity-associated metabolic disorders. Yoshino et al. (2021) now provide the clinical evidence that an NAD+ booster increases muscle insulin sensitivity in postmenopausal prediabetic women, validating the therapeutic promises of NAD+ boosters in humans.
科研通智能强力驱动
Strongly Powered by AbleSci AI